- San Diego-based Orexigen Therapeutics has appointed Michael Narachi as president and CEO. Narachi succeeds Eckard Weber M.D., executive chairman and interim president and CEO. Narachi, 50, had been CEO and president of Ren Pharmaceuticals
- Nabriva Therapeutics has announced the appointment of Dr. David Chiswell as its chief executive officer.
- Akorn has named Jeffrey A. Whitnell as interim CEO.
- Biogen Idec has named Robert A. Hamm as its chief operating officer.
- Among a slate of new appointments, Shigenori Ohkawa, Ph.D., was named chief scientific officer at Takeda.
- NovaDel Pharma announced that Michael E. Spicer has resigned as chief financial officer and corporate secretary in order to accept a position at another company.
- BrainCells named Dr. Philip Jochelson as chief medical officer and Jason Levin as chief business officer.
- BioStorage Technologies has promoted Lori Ball to the newly created role of senior vice president.
- Dr. Nancy Boman is joining Acucela as vice president of clinical development and regulatory affairs.
- Codexis announced that Lori Giver, Ph.D., has been named to the new position of vice president, systems biology for Codexis Bioindustrials.
- MacroGenics has appointed Eric Risser as vice president, business development.
- Acura Pharmaceuticals named Garth Boehm, Ph.D. vice president, modified release dosage form development.
- Covalon Technologies announced that Abe Schwartz has agreed to serve as advisor to the company.
- Endo Pharmaceuticals has named Nancy J. Hutson, Ph.D., to the company's board of directors.
- Valeant Pharmaceuticals International named Steve Stefano to its board of directors.
- AVI BioPharma named Christopher S. Henney, D. Sc. and M. Kathleen Behrens, Ph.D. to the company's board of directors. The company also announced that Director John Fara, Ph.D. has decided that he will not stand for re-election to the board at the company's upcoming annual meeting.
- Geron Corporation announced the appointment of Karin Eastham to its board of directors.
- Dr. Reza Fassihi and Gregory Weaver submitted their resignations as board members of Scolr Pharma.
- Otonomy's science advisory board has been introduced. They are: Rick Friedman, M.D., Ph.D.; Jeffrey Harris, M.D., Ph.D.; Allen Ryan, Ph.D.; Stephan Heller, Ph.D.; Charles Liberman, Ph.D.; Christopher Post, M.D., Ph.D.; and Alec Salt, Ph.D.
- FORMA Therapeutics has added three new members to its scientific advisory board. The new members are: Robert Gould, Ph.D., Simon Campbell and Yigong Shi, Ph.D.
- Novexel has appointed Dr. Karen Bush to the company's scientific advisory board.
- Cellumen named former Pfizer executive Dr. Jack A. Reynolds to its board of directors.
